Pharmaceutical Industry's Sales Growth Estimated to Beat 23 Percent This Year

Source: China Securities Journal, ChinaScope Financial (Data)

+       YU Mingde, Chairman of China Pharmaceutical Enterprises Association (CPEA), predicted that sales revenue in China’s pharmaceutical industry will grow more than 23 percent this year, with profits up 18-19 percent year-on-year. But the growth rates of sales and profits may decline.

+       WU Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), said that, with the reorganization of the current drug and medical system, China’s pharmaceutical industry will grow steadily. The Chinese government will promote enterprises to go global in order to speed up the internationalization of Chinese medicines and drugs.

+       Data from the National Development and Reform Commission (NDRC) shows that in the first seven months, total output value of China’s pharmaceutical industry was CNY 983 billion, up 19.2 percent year-on-year.

China’s pharmaceutical industry has experienced some setbacks in 2012, but growth prospects remain strong.

If you'd like to receive a daily e-mail update of ChinaScope Daily Dim Sum Newsletter, please contact us:newsletter@chinascopefinancial.com. If you'd like to try out ChinaScope Database, apply for a trial here